TLDR A woman regrew her hair after receiving injections of special cell-derived vesicles.
This case report details the successful treatment of a 36-year-old woman with persistent chemotherapy-induced alopecia (PCIA) using extracellular vesicles (EVs) derived from human placental mesenchymal stromal cells (MSCs). The patient, who had undergone chemotherapy for invasive ductal carcinoma, experienced no significant hair regrowth for 18 months post-treatment. She received subcutaneous injections of MSC-derived EVs every 4 weeks for 3 months, resulting in complete regrowth of terminal hair on her scalp. The study suggests that MSC-derived EVs could be a potential treatment for PCIA, though further research with a larger patient cohort is necessary to confirm these findings.
13 citations
,
December 2021 in “Journal of Cellular and Molecular Medicine” Exosome-enriched vesicles from placental cells improved skin condition in a patient with chronic graft-versus-host disease.
44 citations
,
April 2021 in “Frontiers in Cell and Developmental Biology” MSC-derived exosomes may help in skin repair and regeneration.
113 citations
,
November 2017 in “Scientific Reports” Tiny particles from stem cells help activate hair growth cells and encourage hair growth in mice without being toxic.
57 citations
,
March 2011 in “The American Journal of Dermatopathology” Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.
48 citations
,
September 2010 in “PubMed” Chemotherapy often causes hair loss, which is distressing for many, but usually reversible.
September 2025 in “Clinical Cosmetic and Investigational Dermatology” Exosome therapy shows promise for hair growth with minimal side effects, but more research is needed.
December 2024 in “International Journal of Molecular Sciences” Human umbilical cord stem cell vesicles may help treat aging and related diseases.
1 citations
,
July 2025 in “Stem Cell Research & Therapy” Stem cell technology may improve hair loss treatments by providing more effective and personalized options.
55 citations
,
August 2024 in “Heliyon” Stem cell transplantation shows promise for treating diseases but faces challenges like safety, ethics, and cost.
December 2025 in “Pharmaceutics” EV-based drug delivery shows promise but faces challenges in standardization and scalability.
